Status: Recruiting
HER2-positive Breast Cancer Registry
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Priyanka SharmaUpdated: Sep 10, 2025Locations: 6Duration: 10 Years
Eligibility criteria
Stage I-IV HER2-positive breast cancer
None